期刊
JACC-HEART FAILURE
卷 9, 期 7, 页码 471-481出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.jchf.2021.02.006
关键词
cardiac rehabilitation; exercise training; heart failure; health care utilizatin; Medicare; predictors
资金
- Texas Health Resources Clinical Scholarship
- Gilead Sciences Research Scholar Program
- Applied Therapeutics
- National Institute of Aging [1R03AG067960-01]
- Abbott
- American Regent
- Amgen
- AstraZeneca
- Bayer
- Boehringer Ingelheim/Eli Lilly
- Boston Scientific
- Cytokinetics
- Fast BioMedical
- Gilead
- Innolife
- Medtronic
- Merck
- Novartis
- Relypsa
- Respicardia
- Roche
- Sanofi
- Vifor
- Windtree Therapeutics
- American Heart Association
- Intra-Cellular Therapies
- National Heart, Lung, and Blood Institute
- Patient-Centered Outcomes Research Institute
This study aimed to assess the trends and factors associated with cardiac rehabilitation (CR) enrollment and participation among Medicare beneficiaries after the 2014 Medicare coverage expansion. The participation rates of CR among eligible patients with HF were low, with minimal increase since 2014. Factors such as younger age, male sex, nonblack race, previous cardiovascular procedures, and hospitalization at hospitals with CR facilities were associated with CR participation.
OBJECTIVES The purpose of this study was to assess temporal trends and factors associated with cardiac rehabilitation (CR) enrollment and participation among Medicare beneficiaries after the 2014 Medicare coverage expansion. BACKGROUND CR improves exercise capacity, quality of life, and clinical outcomes in heart failure (HF) with reduced ejection fraction (HFrEF). In 2014, Medicare coverage for CR was expanded to include chronic HFrEF. METHODS Among Medicare beneficiaries from quarter (Q) 1 2014 to Q2 2016, 11,696 patients from 14,258 hospitalizations with primary discharge diagnosis of HF were identified. Patients with HF with preserved ejection fraction were excluded. Quarterly CR participation rates among hospitalized HF patients within 6 months of discharge were identified through outpatient administrative claims. The predictors of CR participation were assessed with the use of a multivariable logistic regression model that included patient- and hospital-level characteristics. A secondary analysis to assess participation rates of CR after outpatient encounters for HF was performed. RESULTS Overall, only 611 (4.3%) and 349 (2.2%) eligible patients participated CR after primary hospitalization or outpatient visit for HF, respectively. There was a modest, statistically significant increase in CR participation after HF admissions (2.8% in Q1 2014; 5.0% in Q2 2016; p < 0.001) without significant increase after outpatient visits for HF (2.6% to 3.8%; p = 0.21). Younger age, male sex, nonblack race, previous cardiovascular procedures, and hospitalization at hospitals with available CR facilities were all independently associated with CR participation. CONCLUSIONS CR participation among eligible Medicare beneficiaries with HFrEF was low with minimal increase since 2014 Medicare coverage decision. Sex, race, and institution-dependent variables were independent predictors of CR participation. (C) 2021 by the American College of Cardiology Foundation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据